Literature DB >> 7133358

Early management of aneurysmal subarachnoid hemorrhage.

B Ljunggren, L Brandt, G Sundbärg, H Säveland, S Cronqvist, H Stridbeck.   

Abstract

The Lund Clinic serves a population of 1.46 million inhabitants. During the calendar year 1981, 72 patients presented with a ruptured supratentorial aneurysm, diagnosed either at angiography or at autopsy. Upon admission, 60% of the patients were in good condition and 40% were in poor condition. Eighty-three per cent were admitted within 72 hours after the subarachnoid hemorrhage (SAH). In the total series, 50% made a good recovery; the overall management morbidity was 19% and the management mortality was 31%. Thirty-one patients in Grades I-III underwent early operation (43% of the total series), with a favorable outcome in 74% and 7% mortality. Of the 35 patients who were admitted early and in good condition, 71% made a good recovery, and the management mortality was 9%. These figures may be compared to the 51% favorable outcome and 27% mortality reported from the Cooperative Aneurysm Study with late operation. In the early operation cases, the incidence of significant arterial narrowing at postoperative angiography performed on Day 9 +/- 2 after SAH was 30% and the incidence of permanent neurological deficits of delayed onset was 10%. Two of the early operation patients developed permanent symptomatic hydrocephalus.

Entities:  

Mesh:

Year:  1982        PMID: 7133358     DOI: 10.1227/00006123-198209000-00013

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

1.  Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms.

Authors:  Hae-Kwan Park; Michael Horowitz; Charles Jungreis; Julie Genevro; Christopher Koebbe; Elad Levy; Amin Kassam
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

2.  Stent-assisted coil embolization of wide-necked intracranial aneurysms using a semi-deployment technique: angiographic and clinical outcomes in 31 consecutive patients.

Authors:  X Gao; G Liang; Z Li; H Qu; X Wei
Journal:  Interv Neuroradiol       Date:  2010-12-17       Impact factor: 1.610

3.  Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.

Authors:  J Philippon; R Grob; F Dagreou; M Guggiari; M Rivierez; P Viars
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

4.  The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms.

Authors:  S Sakaki; S Ohta; H Kuwabara; M Shiraishi
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

5.  Ruptured intracranial aneurysms: the overall effect of treatment and the influence of patient selection and data presentation on the reported outcome.

Authors:  R S Maurice-Williams; H Marsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

6.  Management of the ruptured intracranial aneurysm--early surgery, late surgery, or modulated surgery? Personal experience based upon 468 patients admitted in two periods (1972-1984 and 1985-1989).

Authors:  R Deruty; C Mottolese; I Pelissou-Guyotat; J F Soustiel
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

7.  Morbidity and mortality after early aneurysm surgery--a prospective study with nimodipine prevention.

Authors:  J M Gilsbach; A G Harders
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

8.  Aneurysmal bleeding. A plea for early surgery in good-risk patients.

Authors:  R T Thomeer; J C Taal; J H Voormolen; A R Wintzen
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

9.  Intracerebral haematomas from aneurysm rupture: their clinical significance.

Authors:  I Papo; M Bodosi; T Doczi
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

10.  Nimodipine and early aneurysm operation in good condition SAH patients.

Authors:  L M Auer; L Brandt; U Ebeling; J Gilsbach; U Groeger; A Harders; B Ljunggren; F Oppel; H J Reulen; H Saeveland
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.